John Rice

CincyTech is one of the Midwest's most active seed funds, investing in disruptive human health and technology companies in Ohio.

Raised $13,500,000.00 from Ohio Third Frontier.

Harrington Discovery Institute at University Hospitals aims to advance medicine and society.

Airway Therapeutics focuses on pulmonary research program of Cincinnati Children’s Hospital Medical Center for further development.

Raised $38,780,000.00 from Queen City Angels, Cincinnati Children’s, CincyTech and Danmar Capital.

Kurome Therapeutics is a preclinical stage company focused on subverting cancer's ability to evade therapy.

Raised $15,000,000.00 from Affinity Asset Advisors, Queen City Angels, CincyTech and Medicxi.

Armatus Bio is an emerging precision therapeutics company at the intersection of genetic science and bioengineering.

Enable Injections designs and produces on-body delivery systems that allow patients to self-administer large amounts of medication.

Raised $322,000,000.00 from Wood Creek Capital Management, Squarepoint Capital, Cincinnati Children’s, Magnetar Capital, GCM Grosvenor, CincyTech, Cintrifuse and Ohio Innovation Fund.

Genetesis is a medical imaging company leveraging data science and biomagnetism in the fight against cardiovascular disease

Raised $35,810,000.00 from Mithril Capital Management, Wormhole Capital, Ohio Innovation Fund, Cercano Management, JobsOhio and CincyTech.

Xact Medical is developing FIND (Fast Intelligent Needle Delivery), a breakthrough in designing robotics.

Raised $224,993.00 from National Science Foundation.